ERC Pharma Alpha SRL
3.4 FTEThe score of ERC Pharma Alpha shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +5 % Headcount (avg FTE) -19 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ERC Pharma Alpha's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −36,300 € | ||||
| Equity | 492,725 € | ||||
| Cash | 17,988 € | ||||
| EBITDA | −16,922 € | ||||
| Total assets | 880,509 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 16 Dec 2024
- Year ended 31 Dec 2022filed on 25 Sep 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
ERC Pharma Alpha's financial analysis
- Solvency56.0%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ERC Pharma Alpha
ERC Pharma Alpha's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.727.045
- VAT number
- BE0459727045
- Peppol
- Registered · 0208:0459727045 · as of 05 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jan 1997
- Registered office
- 1090 Jette
- Size
- Micro · 3.4 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ERC Pharma Alpha (SRL) has been based in Jette since 1997, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 36,300 € and equity of 492,725 €; its revenue is not published. With 3.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 56.0%, above the median of its sector (37.8%).
Companies similar to ERC Pharma Alpha
Companies in the same business, of comparable size and area, outside its group.
- Pharmavrai Retail sale of pharmaceutical products Huy · balance sheet 880,268 €
- Apotheek De Pot Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 880,893 €
- Apoteek Dreezen Retail sale of pharmaceutical products Hasselt · balance sheet 882,214 €
- Pharmacie des Citronniers Retail sale of pharmaceutical products Brussels · balance sheet 882,658 €
- Cobra Apotheek Rosselaar Retail sale of pharmaceutical products Mol · balance sheet 884,462 €
- Phinn Retail sale of pharmaceutical products Buggenhout · balance sheet 885,031 €
- Lo Farma Retail sale of pharmaceutical products Lochristi · balance sheet 875,320 €
- Pharmazinnes Retail sale of pharmaceutical products Namur · balance sheet 875,224 €
Frequently asked questions about ERC Pharma Alpha
What is the revenue of ERC Pharma Alpha?
ERC Pharma Alpha files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ERC Pharma Alpha?
In Belgium, the VAT number is the company number prefixed with BE: BE0459727045 for ERC Pharma Alpha, if the company is VAT-registered. Its company number (CBE) is 0459.727.045.
Where is the registered office of ERC Pharma Alpha?
According to the CBE register, the registered office of ERC Pharma Alpha is in 1090 Jette.
What is the equity of ERC Pharma Alpha?
At the close of the 2025 financial year, the equity of ERC Pharma Alpha amounts to 492,725 €, a solvency of 56.0% of total assets.
How many people work at ERC Pharma Alpha?
3.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ERC Pharma Alpha?
The register lists 2 active mandates at ERC Pharma Alpha. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ERC Pharma Alpha
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →